Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Degree

Medical Specialty

Submit

Key HIV Studies Influencing My Practice Following IDWeek and HIV Glasgow 2022—Joseph J. Eron, Jr., MD, and Karine Lacombe, MD, PhD

Source: CCO Independent Conference Coverage: Clinical Impact of New HIV Data From Fall 2022 Conferences*

Washington, DC - October 19-23, 2022; Glasgow, Scotland and virtual - October 23-26, 2022

Hear from expert faculty as they present their insights on some of the most clinically relevant new data presented at IDWeek and HIV Glasgow 2022, including prevention strategies, long-acting therapies, and investigational agents.

Joseph J. Eron, Jr., MD

Karine Lacombe, MD, PhD

Released: November 30, 2022

Information on this Educational Activity

Faculty

Joseph J. Eron, Jr., MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Joseph J. Eron, Jr., MD: consultant/advisor/speaker: Gilead Sciences, GlaxoSmithKline, Janssen, Merck, ViiV Healthcare; researcher: Gilead Sciences, ViiV Healthcare.

Karine Lacombe, MD, PhD

Professor
UMR-S1136
Sorbonne University
Professor
Head, Infectious Diseases Department
St Antoine Hospital, AP-HP
Paris, France

Karine Lacombe, MD, PhD: consultant/advisor/speaker: Gilead Sciences, GlaxoSmithKline, Janssen, MSD.

Program Medium

This program has been made available online.

Welcome to the CCO Site

Key HIV Studies Influencing My Practice Following IDWeek and HIV Glasgow 2022—Joseph J. Eron, Jr., MD, and Karine Lacombe, MD, PhD

Information on this Educational Activity

Faculty

Program Medium

Leaving the CCO site